|
Volumn 142, Issue 8, 2006, Pages 1000-1004
|
Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ETRETIN;
LIVER ENZYME;
TRIACYLGLYCEROL;
ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD;
ALOPECIA;
ARTICLE;
CHEILITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG MEGADOSE;
DRY SKIN;
HUMAN;
LIPID METABOLISM;
LOW DRUG DOSE;
MULTICENTER STUDY;
NAIL DISEASE;
PARESTHESIA;
PRIORITY JOURNAL;
PRIVATE PRACTICE;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RHINITIS;
SKIN ABRASION;
SKIN ATROPHY;
SKIN PRURITUS;
TRIACYLGLYCEROL BLOOD LEVEL;
XEROPHTHALMIA;
ACITRETIN;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
KERATOLYTIC AGENTS;
PSORIASIS;
RANDOMIZED CONTROLLED TRIALS;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
|
EID: 33747621615
PISSN: 0003987X
EISSN: 0003987X
Source Type: Journal
DOI: 10.1001/archderm.142.8.1000 Document Type: Article |
Times cited : (50)
|
References (6)
|